PRLD
Prelude Therapeutics IncCompany with tickers: PRLD
CIK
1678660
Shares Outstanding
43,765,011
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-05 | Brusky Sean P. | Chief Business Officer | Other | 0 |
| 2026-03-05 | Brusky Sean P. | Chief Business Officer | Other | 100,000 |
| 2026-02-04 | Combs Andrew | Chief Chemistry Officer | Award | 230,000 |
| 2026-02-04 | Scherle Peggy | Chief Scientific Officer | Award | 230,000 |
| 2026-02-04 | Lim Bryant David | CLO, CFO, Corp Sec. | Award | 275,000 |
| 2026-02-04 | Vaddi Krishna | Director, CEO | Award | 837,000 |
| 2025-11-05 | Sandor Victor | Director | Award | 121,285 |
| 2025-10-17 | Dorton Katina | Director | Award | 76,000 |
| 2025-10-17 | Dorton Katina | Director | Other | 0 |
| 2025-10-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-10-04 | Huang Jane | CMO, Hematology | Tax | 3,355 |
| 2025-10-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-07-04 | Huang Jane | CMO, Hematology | Tax | 3,355 |
| 2025-07-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-07-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-06-12 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 76,000 |
| 2025-06-12 | Dier Mardi | Director | Award | 38,000 |
| 2025-06-12 | FRIEDMAN PAUL A | Director | Award | 38,000 |
| 2025-06-12 | Sandor Victor | Director | Award | 38,000 |
| 2025-06-12 | Bonita David P | Director, 10% Owner | Award | 38,000 |
| 2025-06-12 | Babler Martin | Director | Award | 38,000 |
| 2025-06-12 | Scherer Paul C | Director | Other | 0 |
| 2025-04-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-04-04 | Huang Jane | CMO, Hematology | Tax | 3,355 |
| 2025-04-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-03-25 | Combs Andrew | Chief Chemistry Officer | Buy | 100,000 |
| 2025-03-25 | Vaddi Krishna | Director, CEO | Other | 423,655 |
| 2025-03-25 | Vaddi Krishna | Director, CEO | Buy | 675,000 |
| 2025-03-21 | Vaddi Krishna | Director, CEO | Buy | 15,000 |
| 2025-03-20 | Vaddi Krishna | Director, CEO | Other | 423,655 |
| 2025-03-20 | Vaddi Krishna | Director, CEO | Buy | 5,416 |
| 2025-03-17 | Vaddi Krishna | Director, CEO | Buy | 9,106 |
| 2025-03-14 | Vaddi Krishna | Director, CEO | Other | 423,655 |
| 2025-03-14 | Vaddi Krishna | Director, CEO | Buy | 29,999 |
| 2025-03-13 | Vaddi Krishna | Director, CEO | Buy | 50,000 |
| 2025-03-12 | Vaddi Krishna | Director, CEO | Buy | 47,500 |
| 2025-03-12 | Vaddi Krishna | Director, CEO | Other | 423,655 |
| 2025-02-04 | Scherle Peggy | Chief Scientific Officer | Award | 175,000 |
| 2025-02-04 | Combs Andrew | Chief Chemistry Officer | Award | 175,000 |
| 2025-02-04 | Lim Bryant David | CLO, CFO, Corp Sec. | Award | 200,000 |
| 2025-02-04 | Huang Jane | CMO, Hematology | Award | 200,000 |
| 2025-02-04 | Vaddi Krishna | Director, CEO | Award | 496,000 |
| 2025-01-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-01-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2025-01-04 | Huang Jane | CMO, Hematology | Tax | 3,859 |
| 2024-12-31 | Vaddi Krishna | Director, CEO | Other | 1,167,275 |
| 2024-12-31 | Vaddi Krishna | Director, CEO | Buy | 5,000 |
| 2024-12-30 | Vaddi Krishna | Director, CEO | Other | 1,167,275 |
| 2024-12-30 | Vaddi Krishna | Director, CEO | Buy | 10,000 |
| 2024-12-23 | Combs Andrew | Chief Chemistry Officer | Buy | 60,000 |
| 2024-12-20 | Combs Andrew | Chief Chemistry Officer | Buy | 3,075 |
| 2024-12-19 | Vaddi Krishna | Director, CEO | Buy | 6,888 |
| 2024-12-19 | Lim Bryant David | CLO, CFO, Corp Sec. | Buy | 25,000 |
| 2024-12-18 | Vaddi Krishna | Director, CEO | Other | 551,776 |
| 2024-12-18 | Vaddi Krishna | Director, CEO | Buy | 100,000 |
| 2024-10-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-10-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-10-04 | Huang Jane | CMO, Hematology | Tax | 3,349 |
| 2024-07-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-07-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-07-04 | Huang Jane | CMO, Hematology | Tax | 3,347 |
| 2024-06-14 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 23,500 |
| 2024-06-14 | Sandor Victor | Director | Award | 23,500 |
| 2024-06-14 | Bonita David P | Director, 10% Owner | Award | 23,500 |
| 2024-06-14 | Babler Martin | Director | Award | 23,500 |
| 2024-06-14 | FRIEDMAN PAUL A | Director | Award | 23,500 |
| 2024-06-14 | Dier Mardi | Director | Award | 23,500 |
| 2024-05-14 | Lim Bryant David | CLO, CFO, Corp Sec. | Award | 25,000 |
| 2024-04-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-04-04 | Huang Jane | CMO, Hematology | Tax | 3,347 |
| 2024-04-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-03-01 | Lim Bryant David | CLO, CFO, Corp Sec. | Award | 150,000 |
| 2024-03-01 | Scherle Peggy | Chief Scientific Officer | Award | 150,000 |
| 2024-03-01 | Combs Andrew | Chief Chemistry Officer | Award | 150,000 |
| 2024-03-01 | Huang Jane | CMO, Hematology | Award | 175,000 |
| 2024-03-01 | Vaddi Krishna | Director, CEO | Award | 425,000 |
| 2024-03-01 | Chardonnet Laurent | Chief Financial Officer | Award | 150,000 |
| 2024-01-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-01-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2024-01-04 | Huang Jane | CMO, Hematology | Tax | 3,844 |
| 2023-12-13 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 593,452 |
| 2023-10-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2023-10-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2023-07-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2023-07-04 | Huang Jane | CMO, Hematology | Tax | 3,242 |
| 2023-07-04 | Huang Jane | CMO, Hematology | Convert | 9,375 |
| 2023-06-16 | FRIEDMAN PAUL A | Director | Award | 23,500 |
| 2023-06-16 | Dier Mardi | Director | Award | 23,500 |
| 2023-06-16 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 23,500 |
| 2023-06-16 | Sandor Victor | Director | Award | 23,500 |
| 2023-06-16 | Bonita David P | Director, 10% Owner | Award | 23,500 |
| 2023-06-16 | Babler Martin | Director | Award | 23,500 |
| 2023-05-25 | Vaddi Krishna | Director, CEO | Buy | 900 |
| 2023-05-24 | Vaddi Krishna | Director, CEO | Other | 551,776 |
| 2023-05-24 | Vaddi Krishna | Director, CEO | Buy | 1,000 |
| 2023-05-24 | Lim Bryant David | CLO, CFO, Corp Sec. | Buy | 2,400 |
| 2023-05-23 | Vaddi Krishna | Director, CEO | Buy | 11,856 |
| 2023-05-23 | Vaddi Krishna | Director, CEO | Other | 551,776 |
| 2023-05-23 | Chardonnet Laurent | Chief Financial Officer | Buy | 5,000 |
| 2023-05-22 | Bonita David P | Director, 10% Owner | Buy | 869,565 |